Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke "CLOTBUST-ER"

Terminated

Phase 3 Results N/A

Main Contacts

Name Phone E-mail
Andrew Barreto, MD Principal Investigator
Andrei Alexandrov, MD Principal Investigator
Gordon Brandt, MD Contact (425) 821-1939 gbrandt@cerevast.com
Kevin Peters, PhD Contact 425-821-1603 kpeters@cerevast.com
John Choi, MD Principal Investigator
Jenny Pleas, MS Contact Backup (425) 821-1603 jpleas@cerevast.com
William Likosky, MD Principal Investigator
William Scott Burgin, MD Principal Investigator
Patrick Bobbitt, PhD Contact +41 (0)44 550 0005 pbobbitt@cerevast.com

Contacts by Location

Cerevast Therapeutics, Inc. Redmond, Washington, United States Unknown_status_icon
Kevin Peters, PhD Contact 425-821-1603 kpeters@cerevast.com
Patrick Bobbitt Contact +41 (0)44 550 0005 pbobbitt@cerevast.com
Jenny Pleas Contact Backup (425)821-1603 jpleas@cerevast.com